Peter T. Scardino, MD, FACS -- Chair, Department of Surgery; David H. Koch Chair; Member, Molecular Pharmacology and Chemistry Program

Meet Prostate Cancer Surgeon Peter Scardino

WATCH VIDEO 03:00

Peter T. Scardino, MD, FACS

Surgeon

Titles

David H. Koch Chair

Clinical Expertise

Urologic Oncology; Prostate Cancer

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Scardino accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me

Education

MD, Duke University School of Medicine

Residencies

Surgery - Massachusetts General Hospital; Urology - University of California Los Angeles

Fellowships

National Cancer Institute

Board Certifications

Urology

As Chairman of the Department of Surgery for more than ten years, I oversaw a department widely recognized for its expertise and innovation in cancer surgery. In addition to my administrative responsibilities, I am a surgeon specializing in prostate cancer. My expertise is in early detection, prognosis, and surgical treatment of prostate cancer. Radical prostatectomy — complete removal of the prostate — can cure many men with prostate cancer. Our team has developed surgical techniques to preserve urinary and sexual function after prostatectomy, and we continue to seek ways to improve quality of life for patients after treatment.

Not all prostate cancers progress in the same way. Many cancers pose little or no threat to life and health, while others grow aggressively and are resistant to treatment. My colleagues and I have pioneered the use of statistical models to predict both the natural progression of prostate cancer and how it will respond to treatment. These predictive tools (nomograms) help us tailor treatment for individual men according to the specific characteristics of their cancer. Today, nomograms are being used to help physicians and patients make medical decisions regarding a variety of other cancers as well, including pancreatic, lung, and breast cancer.

In 2001, I received an NIH grant to establish an ongoing Specialized Program of Research Excellence (SPORE) in prostate cancer at Memorial Sloan Kettering Cancer Center. Our SPORE has an ambitious research program focused on developing therapies appropriate for patients with different types of prostate cancer at different stages of development. We hope to achieve this by using molecular and genetic data to improve our prediction models for prostate cancer, identifying the critical mechanisms by which prostate cancer grows and spreads, and developing drugs and immunological techniques for treatment-resistant metastatic cancers.

My position at Memorial Sloan Kettering includes appointments as Head of the Prostate Cancer program, Member in the Sloan Kettering Institute’s Molecular Pharmacology Program;  and the incumbent of the David H. Koch Chair. I am also a Professor in the Department of Urology at Weill Cornell Medical College and at SUNY Downstate Medical Center.

I have written many articles and book chapters and edited the Comprehensive Textbook of Genitourinary Oncology. In 2005, with Judith Kelman, I wrote Dr. Peter Scardino’s Prostate Book, a guide to prostate cancer, prostatitis, and benign prostate hyperplasia (BPH). I serve as Editor-in Chief of Nature Clinical Practice Urology, and I am an editorial board member and reviewer for several peer-reviewed journals. I am an active member of the National Academies’ Institute of Medicine and of the American Urological Association.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Selected Books and Book Chapters

Peter Scardino’s Prostate Book: The Complete Guide to Overcoming Prostate Cancer, Prostatitis, and BPH. 2nd ed.  Scardino PT, Kelman J. New York: Penguin Group; 2010.

Comprehensive Textbook of Genitourinary Oncology. 4th ed. Scardino PT, Linehan MW, Zelefsky MJ, Vogelzang NJ, eds. Philadelphia: Lippincott Williams & Wilkins; 2011.

Interventional Techniques in Uro-oncology. Ahmed HU, Arya M, Scardino PT, Emberton M, eds. London: Blackwell Publishing; 2011.

Contemporary Issues in Cancer Imaging: Prostate Cancer. Hricak H, Scardino PT, eds. Cambridge, UK: Cambridge Univ Press; 2009.

“Anatomical radical prostatectomy in the management of localized prostate cancer.” Lin DW, Eastham JA, Scardino PT. In: Management of Prostate Cancer: Advances and Controversies. Cummings KB, ed. New York: Marcel Dekker, Inc. 2005; 55-60.

“The decision-making process for prostate cancer.” Trabulsi EJ, Scardino PT, Kattan MW. In: Prostate Cancer: Science and Clinical Practice. Mydlo JH and Godec CJ, eds. San Diego: Academic Press; 2004: 232-252.

“Carcinoma of the prostate: Radical prostatectomy.”  Scardino PT, Eastham JA. In: Campbell’s Urology. 8th ed. Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ, eds. Philadelphia: W.B. Saunders; 2002.

 

Publications on PubMed

Visit PubMed for a full listing of Dr. Scardino’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.